| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/09/1992 | CA2062376A1 Medicinal composition |
| 09/09/1992 | CA2061891A1 Flunarizine containing anti-neoplastic compositions |
| 09/08/1992 | WO1992015593A1 New imidazopyridines as serotonergic 5-ht3 antagonists |
| 09/08/1992 | WO1992015591A1 Tetracyclic imidazoquinazoline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/08/1992 | WO1992015590A1 New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents |
| 09/08/1992 | WO1992015587A1 Antibacterial condensed carbapenemes |
| 09/08/1992 | WO1992015586A1 Antibacterial condensed carbapenemes |
| 09/08/1992 | US5145990 Dehydropeptidase, carbapenicillin potentiation |
| 09/08/1992 | US5145985 Process for the preparation of anti-hypertensive benzopyran derivative |
| 09/08/1992 | US5145975 Naphthoquinone derivatives |
| 09/08/1992 | US5145871 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment |
| 09/08/1992 | US5145870 Aryloxyphenylpropylamines their preparation and use |
| 09/08/1992 | US5145868 Alkanophenones useful for treating allergies |
| 09/08/1992 | US5145867 Sickle-cell anemia |
| 09/08/1992 | US5145866 Method of treating anxiety with the aid of r(+)-3-amino-1-hydroxy-pyrrolidin-2-one |
| 09/08/1992 | US5145865 Phenylcarboxylic acid derivatives having hetero ring |
| 09/08/1992 | US5145864 Reduction of voluntary alcohol consumption by treatment with angiotensin converting enzyme inhibitors |
| 09/08/1992 | US5145863 Porphyrin compounds |
| 09/08/1992 | US5145862 Topa hydantoin oxidizer, blocking excess glutamate to N-methyl-D-aspartate(NMDA) receptors |
| 09/08/1992 | US5145859 Methods of treating interstitial cystitis and urethral syndrome |
| 09/08/1992 | US5145857 Hmg-coa reductase-inhibiting substituted amino-pyridines |
| 09/08/1992 | US5145853 Bactericidal formulations for use in veterinary medicine |
| 09/08/1992 | US5145852 Vaso-active medicament to treat impotence |
| 09/08/1992 | US5145851 Method for treating urinary obstruction |
| 09/08/1992 | US5145850 Imidazopyridazines, their production and use |
| 09/08/1992 | US5145849 Indolylpropanols and preparations containing the compounds |
| 09/08/1992 | US5145848 Amino anthracenediones-bis platinum complexes, useful as antitumoral agents |
| 09/08/1992 | US5145847 Antiestrogens |
| 09/08/1992 | US5145846 Vitamin D3 analogs |
| 09/08/1992 | US5145841 Administering metal complex of xylan polysulfate |
| 09/08/1992 | US5145839 Antitumor, AIDS |
| 09/08/1992 | US5145781 Preparation and uses of alpha-glycosyl rutin |
| 09/08/1992 | US5145686 Topical pharmaceutical compositions |
| 09/08/1992 | US5145685 Skin treatment method and composition |
| 09/08/1992 | US5145683 Nifedipine-containing pharmaceutical compositions and process for the preparation thereof |
| 09/08/1992 | US5145682 Estrogen |
| 09/08/1992 | US5145674 Analgesic, antioxidant, herbicide |
| 09/08/1992 | US5145611 Diabetes |
| 09/08/1992 | CA2105675A1 Heterocyclic compounds and their preparation and use |
| 09/08/1992 | CA2105388A1 Antibacterial condensed carbapenemes |
| 09/08/1992 | CA2104777A1 Heterocyclic compounds |
| 09/08/1992 | CA2082415A1 Meso-azacyclic aromatic acid amides and esters as novel serotonergic agents |
| 09/08/1992 | CA2082414A1 Imidazopyridines as serotonergic 5-ht3 antagonists |
| 09/08/1992 | CA2062483A1 Chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/08/1992 | CA2062468A1 Process for the preparation of aryl (or heteroaryl) piperazinylbutylazole derivatives |
| 09/08/1992 | CA2062378A1 Trisubstituted triazimes and pyrimidines, process for their preparation and pharmaceutical compositions containing them |
| 09/08/1992 | CA2062370A1 Pharmaceutical preparation |
| 09/08/1992 | CA2061643A1 Optically active and racemic hydrated diacetylesters of .alpha.-glycero-phosphoryl-choline |
| 09/08/1992 | CA2037727A1 Removing lps pyrogen from aqueous solution |
| 09/08/1992 | CA1307289C2 Peptidylaminodiols |
| 09/08/1992 | CA1307288C Chemical compounds |
| 09/08/1992 | CA1307279C Octahydro indenofuran derivatives, their preparation and therapeutic compositions containing the same |
| 09/08/1992 | CA1307278C Sulfonium compounds, processes for preparing the compounds and pharmacological compositions containing the same |
| 09/08/1992 | CA1307277C Process for the preparation of a stable modification of torasemide and pharmaceutical compositions containing it |
| 09/08/1992 | CA1307271C (1h-azo-1-ylmethyl)substituted benzotriazole derivatives |
| 09/08/1992 | CA1307267C Hmg-coa reductase inhibitors |
| 09/08/1992 | CA1307266C Hmg-coa reductase inhibitors |
| 09/08/1992 | CA1307265C Hmg-coa reductase inhibitors |
| 09/08/1992 | CA1307263C Hmg-coa reductase inhibitors |
| 09/08/1992 | CA1307259C Quinone amides, their production and use |
| 09/08/1992 | CA1307257C PROCESS OF PREPARATION OF 17,21-DIACYLATES OF 9.alpha.- CHLORO-17,21-DIHYDROXY-CORTICOSTEROIDS |
| 09/08/1992 | CA1307256C Bbm-1675c and d antitumor antibiotics |
| 09/08/1992 | CA1307222C Thiadiazole antiviral agents |
| 09/08/1992 | CA1307207C Steroid lotion |
| 09/08/1992 | CA1307206C Antibacterial agent for mammal use comprising cephalosporin derivatives as an effective ingredient |
| 09/07/1992 | CA2062211A1 Substituted 1(2h)-isoquinolinones |
| 09/07/1992 | CA2062132A1 Substituted fused pyrimidinones |
| 09/07/1992 | CA2061653A1 Oral gallium complexes |
| 09/06/1992 | WO1992015546A1 Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis |
| 09/06/1992 | WO1992015304A2 Kappa receptor agonists in the treatment of cerebral ischaemia |
| 09/06/1992 | CA2105589A1 Pharmaceuticals |
| 09/06/1992 | CA2105571A1 Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis |
| 09/05/1992 | WO1992015332A1 Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
| 09/05/1992 | CA2104684A1 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
| 09/05/1992 | CA2061906A1 Novel steroid derivative |
| 09/03/1992 | WO1992014813A1 Neuroprotectant agents |
| 09/03/1992 | WO1992014757A1 Endothelial cell-monocyte adhesion molecule |
| 09/03/1992 | WO1992014743A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 09/03/1992 | WO1992014737A1 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 09/03/1992 | WO1992014731A1 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL |
| 09/03/1992 | WO1992014730A1 Thiazolidine-2,4-dione derivative, salt thereof, and production thereof |
| 09/03/1992 | WO1992014727A1 3-piperidinylmethylcarboxylate substituted indoles |
| 09/03/1992 | WO1992014719A1 Thiazolidine-2,4-dione derivative, salt thereof, and production of the same |
| 09/03/1992 | WO1992014710A1 Novel ureas and thioureas, preparation thereof and application in therapy |
| 09/03/1992 | WO1992014707A1 Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them |
| 09/03/1992 | WO1992014704A1 2-substituted-2-imidazolines |
| 09/03/1992 | WO1992014697A1 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
| 09/03/1992 | WO1992014477A1 Method of treating systemic lupus erythematosus |
| 09/03/1992 | WO1992014476A1 Method of treating pulmonary inflammation |
| 09/03/1992 | WO1992014473A1 Steroid formulations |
| 09/03/1992 | WO1992014472A1 Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts |
| 09/03/1992 | WO1992014471A1 Treatment of non-small cell lung carcinoma |
| 09/03/1992 | WO1992014469A1 Treatment of ovarian cancer |
| 09/03/1992 | WO1992014468A1 Psoriasis treatment |
| 09/03/1992 | WO1992014467A1 Therapeutic agents for the treatment of multidrug resistance to cancers |
| 09/03/1992 | WO1992014466A1 Pharmaceutical antitussive compositions |
| 09/03/1992 | WO1992014465A1 Use of annulated tetrahydropyridinacetic acid derivates for treating neurological diseases |
| 09/03/1992 | WO1992014464A1 Use of sigma receptor antagonists for treatment of cocaine abuse |
| 09/03/1992 | WO1992014463A1 Use of sigma receptor antagonists for treatment of amphetamine abuse |
| 09/03/1992 | WO1992014462A1 Cytokine inhibitors |